Literature DB >> 3401097

Serum myoglobin levels in patients with ischemic myocardial insult.

A Isakov1, I Shapira, M Burke, C Almog.   

Abstract

Serum myoglobin levels were studied in 178 consecutive patients admitted for chest pain due to ischemic cardiac injury. Serum myoglobin level was compared with the clinical condition, electrocardiographic changes, and serum creatine kinase levels. Elevated serum myoglobin concentration was present in all patients with acute myocardial infarction, as defined by World Health Organization, Geneva, criteria, and, in addition, in about 50% of patients with so-called acute coronary insufficiency. On this basis we could define two different groups of patients with acute coronary insufficiency: cases exhibiting elevated serum myoglobin levels (group 1) and those with normal levels (group 2). In group 1 although creatine kinase levels were in the normal range, they were significantly higher than in group 2. Four patients from group 1 developed heart failure and another a typical acute myocardial infarction during hospitalization, whereas no patients of group 2 had such complications. In patients with acute myocardial infarction, the elevation of serum myoglobin preceded that of creatine kinase in most cases. Myoglobin release appears to be related to infarct size, the highest levels were found in extensive myocardial infarction and less marked elevations in cases of subendocardial infarction and in half of the cases with acute coronary insufficiency. It is proposed that serum myoglobin is a reliable measure of myocardial necrosis and serves to detect a hitherto undefined population of small-size acute myocardial infarction, with its attendant clinical and prognostic implications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3401097

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction.

Authors:  R J de Winter; R W Koster; J H Schotveld; A Sturk; J P van Straalen; G T Sanders
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

2.  Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin.

Authors:  J Mair; E Artner-Dworzak; P Lechleitner; B Morass; J Smidt; I Wagner; F Dienstl; B Puschendorf
Journal:  Br Heart J       Date:  1992-11

3.  Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB.

Authors:  H E Bøtker; J Ravkilde; P Søgaard; P J Jørgensen; M Hørder; K Thygesen
Journal:  Br Heart J       Date:  1991-02

4.  Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man.

Authors:  A H Kleine; J F Glatz; F A Van Nieuwenhoven; G J Van der Vusse
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

5.  Usefulness of myosin in the postmortem diagnosis of myocardial damage.

Authors:  M D Pérez-Cárceles; E Osuna; D N Vieira; A Luna
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.